138 related articles for article (PubMed ID: 18093597)
1. Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization.
Naples M; Federico LM; Xu E; Nelken J; Adeli K
Atherosclerosis; 2008 May; 198(1):94-103. PubMed ID: 18093597
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia.
Chong T; Naples M; Federico L; Taylor D; Smith GJ; Cheung RC; Adeli K
Atherosclerosis; 2006 Mar; 185(1):21-31. PubMed ID: 16002078
[TBL] [Abstract][Full Text] [Related]
3. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity.
Mangaloglu L; Cheung RC; Van Iderstine SC; Taghibiglou C; Pontrelli L; Adeli K
Metabolism; 2002 Apr; 51(4):409-18. PubMed ID: 11912545
[TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.
Guo H; Lv H; Tang W; Chi J; Liu L; Xu F; Ji Z; Zhai X; Peng F
Cardiovasc Drugs Ther; 2012 Oct; 26(5):375-82. PubMed ID: 22918601
[TBL] [Abstract][Full Text] [Related]
5. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance.
Taghibiglou C; Rashid-Kolvear F; Van Iderstine SC; Le-Tien H; Fantus IG; Lewis GF; Adeli K
J Biol Chem; 2002 Jan; 277(1):793-803. PubMed ID: 11598116
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.
Basciano H; Miller AE; Naples M; Baker C; Kohen R; Xu E; Su Q; Allister EM; Wheeler MB; Adeli K
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E462-73. PubMed ID: 19509184
[TBL] [Abstract][Full Text] [Related]
8. [Rosuvastatin improves insulin sensitivity in overweight rats induced by high fat diet. Role of SIRT1 in adipose tissue].
Valero-Muñoz M; Martín-Fernández B; Ballesteros S; Cachofeiro V; Lahera V; de Las Heras N
Clin Investig Arterioscler; 2014; 26(4):161-7. PubMed ID: 24612843
[TBL] [Abstract][Full Text] [Related]
9. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster.
Carpentier A; Taghibiglou C; Leung N; Szeto L; Van Iderstine SC; Uffelman KD; Buckingham R; Adeli K; Lewis GF
J Biol Chem; 2002 Aug; 277(32):28795-802. PubMed ID: 12048212
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes.
Miersch S; Sliskovic I; Raturi A; Mutus B
Free Radic Biol Med; 2007 Jan; 42(2):270-9. PubMed ID: 17189832
[TBL] [Abstract][Full Text] [Related]
12. Infusion of beta-endorphin improves insulin resistance in fructose-fed rats.
Su CF; Chang YY; Pai HH; Liu IM; Lo CY; Cheng JT
Horm Metab Res; 2004 Aug; 36(8):571-7. PubMed ID: 15326568
[TBL] [Abstract][Full Text] [Related]
13. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.
Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS
Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy.
Kim S; Kim CH; Vaziri ND
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E813-7. PubMed ID: 15585592
[TBL] [Abstract][Full Text] [Related]
15. Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt signaling pathway in rats.
Li Y; Wang J; Gu T; Yamahara J; Li Y
Toxicol Appl Pharmacol; 2014 Jun; 277(2):155-63. PubMed ID: 24704288
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells.
Huang B; Wu CH; Li FA; Liang SS; Shieh YH; Wang LD
Kaohsiung J Med Sci; 2013 Jul; 29(7):347-52. PubMed ID: 23768697
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
Huang D; Wang FB; Guo M; Li S; Yan ML; Yu T; Wei M; Li JB
Int J Mol Med; 2015 Mar; 35(3):829-38. PubMed ID: 25524396
[TBL] [Abstract][Full Text] [Related]
18. Cinnamon extract inhibits the postprandial overproduction of apolipoprotein B48-containing lipoproteins in fructose-fed animals.
Qin B; Polansky MM; Sato Y; Adeli K; Anderson RA
J Nutr Biochem; 2009 Nov; 20(11):901-8. PubMed ID: 18993048
[TBL] [Abstract][Full Text] [Related]
19. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
20. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine.
Federico LM; Naples M; Taylor D; Adeli K
Diabetes; 2006 May; 55(5):1316-26. PubMed ID: 16644688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
